Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases

Marta Scorsetti, Angelica Facoetti, Piera Navarria, Mario Bignardi, Michela De Santis, Stefania Agostino Ninone, Paola Lattuada, Gaetano Urso, Sabrina Vigorito, Pietro Mancosu, Michele Del Vecchio

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aim: To evaluate the efficacy of different radiotherapy treatment modalities in radioresistant brain metastasis. Patients and Methods: A retrospective analysis was conducted on 78 patients with brain metastases from melanoma, sarcoma, or renal cell carcinoma primary tumours who underwent radiosurgery (20 Gy) and/or hypofractionated stereotactic radiotherapy (6x4 Gy or 7x4 Gy) with or without whole-brain radiotherapy at our Center. Results: The actuarial median survival times for melanoma, renal cell carcinoma and sarcoma were 23, 22 and 7 months respectively, with a significant correlation to recursive partitioning analysis class. Discussion: Our results show that these treatments were effective both in symptom palliation and in improving survival, suggesting that although outcomes generally remained poor in this study population, it is possible and important to control intracranial brain metastases.

Original languageEnglish
Pages (from-to)4259-4263
Number of pages5
JournalAnticancer Research
Volume29
Issue number10
Publication statusPublished - Oct 2009

Fingerprint

Radiosurgery
Radiotherapy
Neoplasm Metastasis
Brain
Renal Cell Carcinoma
Sarcoma
Melanoma
Survival
Therapeutics
Population
Neoplasms

Keywords

  • Melanoma hypofractionated stereotactic radiotherapy (HSRT)
  • Radioresistant brain metastasis
  • Radiosurgery (RS)
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases. / Scorsetti, Marta; Facoetti, Angelica; Navarria, Piera; Bignardi, Mario; De Santis, Michela; Ninone, Stefania Agostino; Lattuada, Paola; Urso, Gaetano; Vigorito, Sabrina; Mancosu, Pietro; Del Vecchio, Michele.

In: Anticancer Research, Vol. 29, No. 10, 10.2009, p. 4259-4263.

Research output: Contribution to journalArticle

Scorsetti, Marta ; Facoetti, Angelica ; Navarria, Piera ; Bignardi, Mario ; De Santis, Michela ; Ninone, Stefania Agostino ; Lattuada, Paola ; Urso, Gaetano ; Vigorito, Sabrina ; Mancosu, Pietro ; Del Vecchio, Michele. / Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases. In: Anticancer Research. 2009 ; Vol. 29, No. 10. pp. 4259-4263.
@article{07971bf73f8b4dd0a3affca4c0cb5dca,
title = "Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases",
abstract = "Aim: To evaluate the efficacy of different radiotherapy treatment modalities in radioresistant brain metastasis. Patients and Methods: A retrospective analysis was conducted on 78 patients with brain metastases from melanoma, sarcoma, or renal cell carcinoma primary tumours who underwent radiosurgery (20 Gy) and/or hypofractionated stereotactic radiotherapy (6x4 Gy or 7x4 Gy) with or without whole-brain radiotherapy at our Center. Results: The actuarial median survival times for melanoma, renal cell carcinoma and sarcoma were 23, 22 and 7 months respectively, with a significant correlation to recursive partitioning analysis class. Discussion: Our results show that these treatments were effective both in symptom palliation and in improving survival, suggesting that although outcomes generally remained poor in this study population, it is possible and important to control intracranial brain metastases.",
keywords = "Melanoma hypofractionated stereotactic radiotherapy (HSRT), Radioresistant brain metastasis, Radiosurgery (RS), Radiotherapy",
author = "Marta Scorsetti and Angelica Facoetti and Piera Navarria and Mario Bignardi and {De Santis}, Michela and Ninone, {Stefania Agostino} and Paola Lattuada and Gaetano Urso and Sabrina Vigorito and Pietro Mancosu and {Del Vecchio}, Michele",
year = "2009",
month = "10",
language = "English",
volume = "29",
pages = "4259--4263",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases

AU - Scorsetti, Marta

AU - Facoetti, Angelica

AU - Navarria, Piera

AU - Bignardi, Mario

AU - De Santis, Michela

AU - Ninone, Stefania Agostino

AU - Lattuada, Paola

AU - Urso, Gaetano

AU - Vigorito, Sabrina

AU - Mancosu, Pietro

AU - Del Vecchio, Michele

PY - 2009/10

Y1 - 2009/10

N2 - Aim: To evaluate the efficacy of different radiotherapy treatment modalities in radioresistant brain metastasis. Patients and Methods: A retrospective analysis was conducted on 78 patients with brain metastases from melanoma, sarcoma, or renal cell carcinoma primary tumours who underwent radiosurgery (20 Gy) and/or hypofractionated stereotactic radiotherapy (6x4 Gy or 7x4 Gy) with or without whole-brain radiotherapy at our Center. Results: The actuarial median survival times for melanoma, renal cell carcinoma and sarcoma were 23, 22 and 7 months respectively, with a significant correlation to recursive partitioning analysis class. Discussion: Our results show that these treatments were effective both in symptom palliation and in improving survival, suggesting that although outcomes generally remained poor in this study population, it is possible and important to control intracranial brain metastases.

AB - Aim: To evaluate the efficacy of different radiotherapy treatment modalities in radioresistant brain metastasis. Patients and Methods: A retrospective analysis was conducted on 78 patients with brain metastases from melanoma, sarcoma, or renal cell carcinoma primary tumours who underwent radiosurgery (20 Gy) and/or hypofractionated stereotactic radiotherapy (6x4 Gy or 7x4 Gy) with or without whole-brain radiotherapy at our Center. Results: The actuarial median survival times for melanoma, renal cell carcinoma and sarcoma were 23, 22 and 7 months respectively, with a significant correlation to recursive partitioning analysis class. Discussion: Our results show that these treatments were effective both in symptom palliation and in improving survival, suggesting that although outcomes generally remained poor in this study population, it is possible and important to control intracranial brain metastases.

KW - Melanoma hypofractionated stereotactic radiotherapy (HSRT)

KW - Radioresistant brain metastasis

KW - Radiosurgery (RS)

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=71949089780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949089780&partnerID=8YFLogxK

M3 - Article

C2 - 19846983

AN - SCOPUS:71949089780

VL - 29

SP - 4259

EP - 4263

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -